IOF Accelerator: Camelidae-derived single domain antibody fragments for theranosis of cancer

Project Details


The accelerator budget will be invested in the development of an automated synthesis procedure for 18F labeled sdAbs in a GMP compliant procedure to allow clinical trials using PET/CT. At VUB we develop a pipeline of sdAb based diagnostics for imaging cancer cells and immune cell in the tumor microenvironment. The investment will accelerate the clinical translation of these imaging drugs.
Effective start/end date21/12/1820/12/21

Flemish discipline codes

  • Cancer therapy


  • automated synthesis
  • clinical trials